| Year | Team | G | IP | ERA | K | SV | WHIP | K/9 |
|---|---|---|---|---|---|---|---|---|
| 2021 | TOR | 61 | 60.1 | 2.24 | 83 | 23 | 1.01 | 12.4 |
| 2022 | TOR | 60 | 61.0 | 2.11 | 72 | 36 | 1.00 | 10.6 |
| 2023 | TOR | 57 | 57.1 | 2.67 | 73 | 36 | 1.06 | 11.5 |
| 2024 | TOR | 23 | 22.2 | 4.37 | 26 | 8 | 1.46 | 10.3 |
| 2025 | TOR/LAA | 31 | 30.0 | 3.30 | 35 | 5 | 1.20 | 10.5 |
| 2026 ST | LAA | — | — | — | — | — | — | — |
The Splitter Is Real. The Elbow History Is Also Real.
At his best — three seasons from 2021 to 2023 — Jordan Romano was one of the most reliable setup men in the American League. Sub-2.50 ERA across 180 innings, a splitter that generated genuine swing-and-miss at 10+ K/9, and the ability to handle the 7th and 8th in high-leverage situations. The Angels got that pitcher for $2 million.
The caveat is real and it deserves to be stated plainly: Romano's elbow has been a recurring issue. He missed most of 2024, appeared in only 31 games in 2025 across two organizations. The elbow recovery is described as on track this spring, and his Feb 24 outing (1 IP, 0 ER, 1K vs San Francisco) was clean.
Low investment, high ceiling. At $2M on a one-year deal, the Angels are paying for upside with essentially no downside risk. If Romano is healthy and his splitter is working, he is an elite setup option who gives Yates or Joyce support in the back of the bullpen. That is an enormous value if the health cooperates.